170 related articles for article (PubMed ID: 24934552)
1. Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines.
Foglietta F; Serpe L; Canaparo R; Vivenza N; Riccio G; Imbalzano E; Gasco P; Zara GP
J Pharm Pharm Sci; 2014; 17(2):231-47. PubMed ID: 24934552
[TBL] [Abstract][Full Text] [Related]
2. Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells.
Serpe L; Laurora S; Pizzimenti S; Ugazio E; Ponti R; Canaparo R; Briatore F; Barrera G; Gasco MR; Bernengo MG; Eandi M; Zara GP
Anticancer Drugs; 2004 Jun; 15(5):525-36. PubMed ID: 15166628
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.
Davis T; Kennedy C; Chiew YE; Clarke CL; deFazio A
Clin Cancer Res; 2000 Nov; 6(11):4334-42. PubMed ID: 11106251
[TBL] [Abstract][Full Text] [Related]
4. Improved In Vitro Antileukemic Activity of All-Trans Retinoic Acid Loaded in Cholesteryl Butyrate Solid Lipid Nanoparticles.
Silva EL; Lima FA; Carneiro G; Ramos Jonas Periera ; Gomes DA; de Souza-Fagundes EM; Ferreira LA
J Nanosci Nanotechnol; 2016 Feb; 16(2):1291-300. PubMed ID: 27433579
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid.
Silva EL; Carneiro G; Caetano PA; Goulart G; Ferreira Costa D; de Souza-Fagundes EM; Gomes DA; Ferreira LA
Expert Rev Anticancer Ther; 2015 Feb; 15(2):247-56. PubMed ID: 25611812
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the dietary histone deacetylase inhibitor butyrate alone or in combination with vitamin A against proliferation of MCF-7 human breast cancer cells.
Andrade FO; Nagamine MK; Conti AD; Chaible LM; Fontelles CC; Jordão Junior AA; Vannucchi H; Dagli ML; Bassoli BK; Moreno FS; Ong TP
Braz J Med Biol Res; 2012 Sep; 45(9):841-50. PubMed ID: 22714808
[TBL] [Abstract][Full Text] [Related]
7. Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells.
Shin H; Lee YS; Lee YC
Oncol Rep; 2012 Apr; 27(4):1111-5. PubMed ID: 22160140
[TBL] [Abstract][Full Text] [Related]
8. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
9. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of butyrate analogues in HT-29 cancer cells.
Ooi CC; Good NM; Williams DB; Lewanowitsch T; Cosgrove LJ; Lockett TJ; Head RJ
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):482-9. PubMed ID: 19930426
[TBL] [Abstract][Full Text] [Related]
11. Repurposing itraconazole to the benefit of skin cancer treatment: A combined azole-DDAB nanoencapsulation strategy.
Carbone C; Martins-Gomes C; Pepe V; Silva AM; Musumeci T; Puglisi G; Furneri PM; Souto EB
Colloids Surf B Biointerfaces; 2018 Jul; 167():337-344. PubMed ID: 29684903
[TBL] [Abstract][Full Text] [Related]
12. The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines.
Batova A; Shao LE; Diccianni MB; Yu AL; Tanaka T; Rephaeli A; Nudelman A; Yu J
Blood; 2002 Nov; 100(9):3319-24. PubMed ID: 12384433
[TBL] [Abstract][Full Text] [Related]
13. The histone deacetylase inhibitor sodium butyrate induces DNA topoisomerase II alpha expression and confers hypersensitivity to etoposide in human leukemic cell lines.
Kurz EU; Wilson SE; Leader KB; Sampey BP; Allan WP; Yalowich JC; Kroll DJ
Mol Cancer Ther; 2001 Dec; 1(2):121-31. PubMed ID: 12467229
[TBL] [Abstract][Full Text] [Related]
14. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest.
Yang H; Xu W; Li Y; Lan P; Zhang J; Zhang Y; Zhang C
Anticancer Drugs; 2014 Aug; 25(7):767-77. PubMed ID: 24686006
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor sodium butyrate suppresses DNA double strand break repair induced by etoposide more effectively in MCF-7 cells than in HEK293 cells.
Li L; Sun Y; Liu J; Wu X; Chen L; Ma L; Wu P
BMC Biochem; 2015 Jan; 16():2. PubMed ID: 25592494
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors.
McBain JA; Eastman A; Nobel CS; Mueller GC
Biochem Pharmacol; 1997 May; 53(9):1357-68. PubMed ID: 9214697
[TBL] [Abstract][Full Text] [Related]
17. Butyrate directly decreases human gut lamina propria CD4 T cell function through histone deacetylase (HDAC) inhibition and GPR43 signaling.
Kibbie JJ; Dillon SM; Thompson TA; Purba CM; McCarter MD; Wilson CC
Immunobiology; 2021 Sep; 226(5):152126. PubMed ID: 34365090
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells.
Miao J; Du YZ; Yuan H; Zhang XG; Hu FQ
Colloids Surf B Biointerfaces; 2013 Oct; 110():74-80. PubMed ID: 23711779
[TBL] [Abstract][Full Text] [Related]
19. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
20. Neutrophilic differentiation modulates the apoptotic response of HL-60 cells to sodium butyrate and sodium valproate.
Vrba J; Dolezel P; Ulrichova J
Neoplasma; 2010; 57(5):438-48. PubMed ID: 20568898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
